Skip to main content
# Title Department Research Member Research Year
911 Comparison Between the Effects of Intravenous Morphine,
Tramadol, and Ketorolac on Stress and Immune Responses
in Patients Undergoing Modified Radical Mastectomy
Department of Anesthesia, Intensive care and Pain management Prof. Sahar Abdel Baky Mohamed Ahmad 2016
912 Excision Repair Cross-Complementation Group 1 (ERCC1): A Prognostic and Predictive Biomarker in Patients with Colorectal Cancer Receiving Adjuvant Oxaliplatin Based Chemotherapy Department of Radiotherapy and Nuclear medicine Dr. Shaimaa / Elsayyed Youssef / Ahmed 2016
913 Alvimopan in the setting of colorectal resection with an ostomy: To use or not to use? Department of Surgical Oncology Dr. Murad Aly Jabir Ahmed 2016
914 Comparison of three different doses sugammadex based on ideal body weight for reversal of moderate rocuronium-induced neuromuscular blockade in laparoscopic bariatric surgery. Department of Anesthesia, Intensive care and Pain management Dr. Ahmed Mohamed Abdel Rahman Osman 2016
915 Vulvar Cancer Surgical Treatment Complications Management; 5 Years Experience, SECI Department of Surgical Oncology Dr. Mahmoud Hussein Abdel-Azim Badawi 2016
916 Patterns of Failure and Survival in Patients with Nasopharyngeal carcinoma treated with Intensity Modulated Radiation Therapy in Saudi Arabia Department of Medical Oncology Dr. Ashraf Mohamed El-Yamany 2016
917 Transdermal Fentanyl for Cancer Pain
Management in Opioid-Naive Pediatric
Cancer Patients
Department of Pediatric Oncology Prof. Heba Abdel-Razik Sayed Hussein 2016
918 ERCC1, as Prognostic and Predictive Marker in Metastatic Colorectal Cancer Patients Treated with Oxaliplatin based Chemotherapy Department of Medical Oncology Dr. Adel Gomaa Mohamed Gabr 2016
919 Hypofractionation versus conventional radiotherapy
with concurrent Gemcitabine in bladder preservation of
patient with bladder carcinoma
Department of Radiotherapy and Nuclear medicine Prof. Hamza Abbas Hamza Mohammed 2016
920 Pretreatment levels of serum osteoprotegerin and p53 protein
and urine telomerase as prognostic factors affecting survival in Egyptian bladder cancer patients
Department of Radiotherapy and Nuclear medicine Prof. Mohamed Ibrahim Mohamed El-Sayed 2016